BIONET Corp. (1784.TWO) has a MoatMap StockRank of 17/100 based on Quality (52/100), Value (23/100), and Momentum (31/100) factor scores. The current signal is STRONG SELL. BIONET Corp., a Taiwanese healthcare company, carries significant geopolitical risk due to its location, which is a major deterrent for a high-conviction portfolio, overriding any potential underlying quality.